$5.98
0.122.05%
Pre-Market: 9:16 AM EDT
15 minutes delayed
Design Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Design Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $-0.21 | $-0.23 | 8.70 % |
Mar 2024 | 2024-05-08 | $-0.20 | $-0.29 | 31.0 % |
Dec 2023 | 2024-03-19 | $-0.21 | $-0.31 | 32.3 % |
Sep 2023 | 2023-11-13 | $-0.28 | $-0.41 | 31.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Design Therapeutics (DSGN) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $-0.21, which beat the estimate of $-0.23.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.